Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches
- PMID: 32388875
- PMCID: PMC7444780
- DOI: 10.1111/bcp.14351
Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches
Abstract
Radiation therapy is an essential component of cancer care, contributing up to 40% of curative cancer treatment regimens. It creates DNA double-strand breaks causing cell death in highly replicating tumour cells. However, tumours can develop acquired resistance to therapy. The efficiency of radiation treatment has been increased by means of combining it with other approaches such as chemotherapy, molecule-targeted therapies and, in recent years, immunotherapy (IT). Cancer-cell apoptosis after radiation treatment causes an immunological reaction that contributes to eradicating the tumour via antigen presentation and subsequent T-cell activation. By contrast, radiotherapy also contributes to the formation of an immunosuppressive environment that hinders the efficacy of the therapy. Innate immune cells from myeloid and lymphoid origin show a very active role in both acquired resistance and antitumourigenic mechanisms. Therefore, many efforts are being made in order to reach a better understanding of the innate immunity reactions after radiation therapy (RT) and the design of new combinatorial IT strategies focused in these particular populations.
Keywords: damage-associated molecular patterns; dendritic cells; immunotherapy; innate and adaptive immunity; myeloid-derived suppressor cells; natural killer cells; radiation therapy; tumour-associated macrophages.
© 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Conflict of interest statement
The authors declare no competing interests.
Figures

References
-
- Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence‐based clinical guidelines. Cancer. 2005;104(6):1129‐1137. - PubMed
-
- Eriksson D, Stigbrand T. Radiation‐induced cell death mechanisms. Tumour Biol. 2010;31(4):363‐372. - PubMed
-
- Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11(4):239‐253. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical